Featured Research

from universities, journals, and other organizations

U.S. And Japanese Scientists Develop New Test For Male Infertility

Date:
February 6, 2001
Source:
European Society For Human Reproduction And Embryology
Summary:
A team of US and Japanese experts in reproductive medicine has made a major advance in testing for male infertility that could prevent women seeking fertility treatment from taking unnecessary tests or having unnecessary treatments.

Jan. 31, 2001 -- A team of US and Japanese experts in reproductive medicine has made a major advance intesting for male infertility that could prevent women seeking fertility treatment from takingunnecessary tests or having unnecessary treatments.

The scientists have developed a method that could make diagnosis more accurate and lead to acorrect diagnosis in cases where doctors can find no apparent cause for a couple's inability toconceive.

Large trials are now starting in the United States and Japan and if these confirm the results ofresearch published today in Human Reproduction, the technology might even be developed as acommercial test kit for wide-scale use.

The researchers are Peter Sutovsky, M.S., Ph.D., and Gerald Schatten, Ph.D., of OregonHealth Sciences University and Yukihiro Terada M.D., Ph.D., from Tohoku University Schoolof Medicine in Sendai, Japan. The research was supported by US National Institutes of Health(NIH), National Institute of Occupational Safety and Health (NIOSH), National Institute ofChild and Human Development (NICHD), and US Department of Agriculture (USDA).

The method, called sperm-ubiquitin tag immunoassay (SUTI) is based on a small protein calledubiquitin. Ubiquitination is a process by which the body breaks down and recycles obsoletecellular proteins. The accumulation of ubiquitin in the sperm cells is evidence of damage ordefect. The researchers used specific antibodies against ubiquitin to screen sperm from 17infertility patients and two fertile donors by microscopy and flow cytometry.

They discovered high levels of ubiquitin antibodies on the surface of cells taken from 13 of the17 infertility patients tested, but not in the two fertile donors. Of the 17 infertility patients, thetest confirmed a previous clinical diagnosis of male infertility in five. Testing also revealedpossible reasons for infertility that had previously been inexplicable in five other patients. Inthree of the patients results suggested that there could be a male contribution to previouslydiagnosed maternal infertility. In another three, testing confirmed a previous diagnosis offemale-only infertility and in one case it showed that the man was unlikely to have been thecause of unexplained infertility.

"Ubiquitin appears to be a universal marker of semen abnormalities, recognising a wide rangeof sperm defects and also contaminants in semen," said Dr Sutovsky. "I think SUTI could bethe first truly objective assay for male infertility, based on an exact, fully automatedmeasurement of a single protein in sperm rather than a subjective analysis of sperm by lightmicroscopy. Its major advantage is its sensitivity. We were able even to diagnose a male factorin cases where conventional semen analysis could not explain infertility. In around one fifth ofall couples, current methods cannot identify a cause. SUTI will be able to provide an answer inat least a portion of these cases."

Dr Terada, whose hospital in Sendai provided the 17 patients, said that while traditional lightmicroscopic analysis of sperm had indisputable value, it often produced inconsistent resultsand did not always recognise some of the hidden intrinsic sperm defects. "This enables a moreaccurate diagnosis and could direct the treatment of infertility towards the man, sparing hispartner excessive examinations and possibly even unnecessary treatments," he said.

The research team believes SUTI may also have a role in future treatment. Dr Schatten said:"Since we now know a specific protein is associated with defective sperm and we haveantibodies against it, there is a chance that we could develop a technique for depleting most ofthe truly defective sperm from semen samples for IVF or intracytoplasmic sperm injection(ICSI) - the process by which an egg is fertilised by injecting a single sperm."


Story Source:

The above story is based on materials provided by European Society For Human Reproduction And Embryology. Note: Materials may be edited for content and length.


Cite This Page:

European Society For Human Reproduction And Embryology. "U.S. And Japanese Scientists Develop New Test For Male Infertility." ScienceDaily. ScienceDaily, 6 February 2001. <www.sciencedaily.com/releases/2001/02/010205074427.htm>.
European Society For Human Reproduction And Embryology. (2001, February 6). U.S. And Japanese Scientists Develop New Test For Male Infertility. ScienceDaily. Retrieved October 20, 2014 from www.sciencedaily.com/releases/2001/02/010205074427.htm
European Society For Human Reproduction And Embryology. "U.S. And Japanese Scientists Develop New Test For Male Infertility." ScienceDaily. www.sciencedaily.com/releases/2001/02/010205074427.htm (accessed October 20, 2014).

Share This



More Health & Medicine News

Monday, October 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Microneedle Patch Promises Painless Pricks

Microneedle Patch Promises Painless Pricks

Reuters - Innovations Video Online (Oct. 18, 2014) Researchers at The National University of Singapore have invented a new microneedle patch that could offer a faster and less painful delivery of drugs such as insulin and painkillers. Video provided by Reuters
Powered by NewsLook.com
Raw: Nurse Nina Pham Arrives in Maryland

Raw: Nurse Nina Pham Arrives in Maryland

AP (Oct. 17, 2014) The first nurse to be diagnosed with Ebola at a Dallas hospital walked down the stairs of an executive jet into an ambulance at an airport in Frederick, Maryland, on Thursday. Pham will be treated at the National Institutes of Health. (Oct. 16) Video provided by AP
Powered by NewsLook.com
Raw: Cruise Ship Returns to US Over Ebola Fears

Raw: Cruise Ship Returns to US Over Ebola Fears

AP (Oct. 17, 2014) A Caribbean cruise ship carrying a Dallas health care worker who is being monitored for signs of the Ebola virus is heading back to Texas, US, after being refused permission to dock in Cozumel, Mexico. (Oct. 17) Video provided by AP
Powered by NewsLook.com
Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

Spanish Govt: Four Suspected Ebola Cases in Spain Test Negative

AFP (Oct. 17, 2014) All four suspected Ebola cases admitted to hospitals in Spain on Thursday have tested negative for the deadly virus in a first round of tests, the government said Friday. Duration: 00:55 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins